MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells

Sharanjot Saini, Soichiro Yamamura, Shahana Majid, Varahram Shahryari, Hiroshi Hirata, Yuichiro Tanaka, Rajvir Dahiya

Research output: Contribution to journalArticle

Abstract

Cancer pathogenesis is restricted by stresses that compromise cell division and survival. In this study, we identify miR-708, a little studied member of a set of microRNAs that have been implicated in stress control, as an important tumor suppressor in renal cell carcinoma (RCC). miR-708 expression was attenuated widely in human RCC specimens. Restoration of miR-708 expression in RCC cell lines decreased cell growth, clonability, invasion, and migration and elicited a dramatic increase in apoptosis. Moreover, intratumoral delivery of miR-708 was sufficient to trigger in vivo regression of established tumors in murine xenograft models of human RCC. Investigation of the targets of miR-708 identified the inhibitor of apoptosis protein survivin as important. siRNA-mediated knockdown of survivin partially phenocopied miR-708 overexpression suggesting that the proapoptotic role of miR-708 may be mediated primarily through survivin regulation. Additionally, we identified the E-cadherin regulators ZEB2 and BMI1 as likely miR-708 targets. Taken together, our findings define a major tumor suppressive role for miR-708, which may offer an attractive new target for prognostic and therapeutic intervention in RCC.

Original languageEnglish (US)
Pages (from-to)6208-6219
Number of pages12
JournalCancer Research
Volume71
Issue number19
DOIs
StatePublished - Oct 1 2011
Externally publishedYes

Fingerprint

MicroRNAs
Renal Cell Carcinoma
Apoptosis
Neoplasms
Inhibitor of Apoptosis Proteins
Cadherins
Heterografts
Cell Division
Small Interfering RNA
Cell Survival
Cell Line
Growth
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Saini, S., Yamamura, S., Majid, S., Shahryari, V., Hirata, H., Tanaka, Y., & Dahiya, R. (2011). MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Research, 71(19), 6208-6219. https://doi.org/10.1158/0008-5472.CAN-11-0073

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. / Saini, Sharanjot; Yamamura, Soichiro; Majid, Shahana; Shahryari, Varahram; Hirata, Hiroshi; Tanaka, Yuichiro; Dahiya, Rajvir.

In: Cancer Research, Vol. 71, No. 19, 01.10.2011, p. 6208-6219.

Research output: Contribution to journalArticle

Saini, S, Yamamura, S, Majid, S, Shahryari, V, Hirata, H, Tanaka, Y & Dahiya, R 2011, 'MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells', Cancer Research, vol. 71, no. 19, pp. 6208-6219. https://doi.org/10.1158/0008-5472.CAN-11-0073
Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, Tanaka Y et al. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Research. 2011 Oct 1;71(19):6208-6219. https://doi.org/10.1158/0008-5472.CAN-11-0073
Saini, Sharanjot ; Yamamura, Soichiro ; Majid, Shahana ; Shahryari, Varahram ; Hirata, Hiroshi ; Tanaka, Yuichiro ; Dahiya, Rajvir. / MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. In: Cancer Research. 2011 ; Vol. 71, No. 19. pp. 6208-6219.
@article{68ccb5cada0f490aae54367f8c0a4396,
title = "MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells",
abstract = "Cancer pathogenesis is restricted by stresses that compromise cell division and survival. In this study, we identify miR-708, a little studied member of a set of microRNAs that have been implicated in stress control, as an important tumor suppressor in renal cell carcinoma (RCC). miR-708 expression was attenuated widely in human RCC specimens. Restoration of miR-708 expression in RCC cell lines decreased cell growth, clonability, invasion, and migration and elicited a dramatic increase in apoptosis. Moreover, intratumoral delivery of miR-708 was sufficient to trigger in vivo regression of established tumors in murine xenograft models of human RCC. Investigation of the targets of miR-708 identified the inhibitor of apoptosis protein survivin as important. siRNA-mediated knockdown of survivin partially phenocopied miR-708 overexpression suggesting that the proapoptotic role of miR-708 may be mediated primarily through survivin regulation. Additionally, we identified the E-cadherin regulators ZEB2 and BMI1 as likely miR-708 targets. Taken together, our findings define a major tumor suppressive role for miR-708, which may offer an attractive new target for prognostic and therapeutic intervention in RCC.",
author = "Sharanjot Saini and Soichiro Yamamura and Shahana Majid and Varahram Shahryari and Hiroshi Hirata and Yuichiro Tanaka and Rajvir Dahiya",
year = "2011",
month = "10",
day = "1",
doi = "10.1158/0008-5472.CAN-11-0073",
language = "English (US)",
volume = "71",
pages = "6208--6219",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "19",

}

TY - JOUR

T1 - MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells

AU - Saini, Sharanjot

AU - Yamamura, Soichiro

AU - Majid, Shahana

AU - Shahryari, Varahram

AU - Hirata, Hiroshi

AU - Tanaka, Yuichiro

AU - Dahiya, Rajvir

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Cancer pathogenesis is restricted by stresses that compromise cell division and survival. In this study, we identify miR-708, a little studied member of a set of microRNAs that have been implicated in stress control, as an important tumor suppressor in renal cell carcinoma (RCC). miR-708 expression was attenuated widely in human RCC specimens. Restoration of miR-708 expression in RCC cell lines decreased cell growth, clonability, invasion, and migration and elicited a dramatic increase in apoptosis. Moreover, intratumoral delivery of miR-708 was sufficient to trigger in vivo regression of established tumors in murine xenograft models of human RCC. Investigation of the targets of miR-708 identified the inhibitor of apoptosis protein survivin as important. siRNA-mediated knockdown of survivin partially phenocopied miR-708 overexpression suggesting that the proapoptotic role of miR-708 may be mediated primarily through survivin regulation. Additionally, we identified the E-cadherin regulators ZEB2 and BMI1 as likely miR-708 targets. Taken together, our findings define a major tumor suppressive role for miR-708, which may offer an attractive new target for prognostic and therapeutic intervention in RCC.

AB - Cancer pathogenesis is restricted by stresses that compromise cell division and survival. In this study, we identify miR-708, a little studied member of a set of microRNAs that have been implicated in stress control, as an important tumor suppressor in renal cell carcinoma (RCC). miR-708 expression was attenuated widely in human RCC specimens. Restoration of miR-708 expression in RCC cell lines decreased cell growth, clonability, invasion, and migration and elicited a dramatic increase in apoptosis. Moreover, intratumoral delivery of miR-708 was sufficient to trigger in vivo regression of established tumors in murine xenograft models of human RCC. Investigation of the targets of miR-708 identified the inhibitor of apoptosis protein survivin as important. siRNA-mediated knockdown of survivin partially phenocopied miR-708 overexpression suggesting that the proapoptotic role of miR-708 may be mediated primarily through survivin regulation. Additionally, we identified the E-cadherin regulators ZEB2 and BMI1 as likely miR-708 targets. Taken together, our findings define a major tumor suppressive role for miR-708, which may offer an attractive new target for prognostic and therapeutic intervention in RCC.

UR - http://www.scopus.com/inward/record.url?scp=80053377344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053377344&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-11-0073

DO - 10.1158/0008-5472.CAN-11-0073

M3 - Article

C2 - 21852381

AN - SCOPUS:80053377344

VL - 71

SP - 6208

EP - 6219

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 19

ER -